Industry
Health Care
Topic
Employment and Board Changes
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Board and Executive Moves in Health Care
... expediting mortgage preapprovals and processing purchase and refinance mortgage applications. Sarah joined Align as a Call Center Representative and was previously a Teller Manager at ...
... a binding vote the compensation of the members of the Board of Directors and the Group Executive Committee. Shareholders re-elect all proposed Board members; Walter ...
... Healogics, the nation's largest provider of advanced chronic wound care services, today announced ...
... the better part of a year. Who's in the hot seat? Former Rosetta Genomics chief Kenneth Berlin. The Princeton, New Jersey-based biotech rang in more ...
... Kush Bottles, Inc. (OTC: KSHB), Cannabis Sativa, Inc. (OTC: CBDS), AXIM Biotechnologies, Inc. (OTC: AXIM), Organigram Holdings Inc. (OTC: OGRMF) Starting January 1st, California the ...
... PaxeraHealth is pleased to welcome Warner (Chuck) Pyne III and Paul Dandrow into ...
... as president of EMD Serono, Inc., the North American biopharmaceutical business of Merck KGaA; president of the Serono Research & Development Institute; and president of ...
... as a Senior Managing Director and co-CEO of its Private Capital Advisory ("PCA") practice, based in San Francisco. Mr. Thompson will expand Evercore's existing real ...
... Kymera Therapeutics LLC, a biotechnology company pioneering targeted-protein degradation as a transformative new approach ...
... the acquisition of GN Otometrics for $145 million on September 25, 2016. Otometrics, which manufactures and sells hearing aid tools to audiologists, thrust Natus into ...
... TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) ("Profound" or the "Company"), the only company to provide ...
... BOTHELL, Wash., April 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc., (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for ...
... Today, Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), named Christopher ...
... Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer ...
... to re-establish the manufacturing infrastructure and have Dr. Kagan work closely with Amarantus' recently appointed Chief Regulatory Advisor Dr. Brian Harvey to engage the FDA ...
... Kaleido Biosciences , a clinical-stage biotechnology company developing novel chemistries to unlock the ...
... CAMBRIDGE - Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of ...
... NEWARK - Depomed, Inc. (NASDAQ:DEPO) today announced the appointment of John B. Thomas as Senior Vice ...
... joining Amarin, Mr. Berg served as President and Chief Executive Officer for Essentialis, Inc., a development stage pharmaceutical company where he led the company's work ...
... Xellia Pharmaceuticals ('Xellia' or the 'Company'), a specialty pharmaceutical company focusing on providing important ...
... to patients in Dallas since 1992, and earned his doctorate from Baylor College of Medicine in Houston, Texas. He served as a pediatric intern at ...
... April 1, 2018. Dr. Peter Lichtlen was Chief Medical Officer at Sucampo Pharmaceuticals Inc. until the company's acquisition by Mallinckrodt Pharmaceuticals earlier this year and ...
Subscribe now for full coverage on Board and Executive Moves in Health Care
Start My Free Trial